$4.69 Billion is the total value of Glenview Capital Management's 57 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 30.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| THC | Sell | TENET HEALTHCARE CORP | $598,551,000 | +4.1% | 7,327,108 | -15.3% | 12.76% | +22.3% |
| MCK | Sell | MCKESSON CORP | $382,761,000 | +10.9% | 1,539,852 | -11.0% | 8.16% | +30.3% |
| BHC | Sell | BAUSCH HEALTH COS INC | $345,184,000 | -20.8% | 12,502,147 | -20.1% | 7.36% | -6.9% |
| CI | Sell | CIGNA CORP NEW | $254,782,000 | -3.8% | 1,109,534 | -16.1% | 5.43% | +13.1% |
| DXC | Sell | DXC TECHNOLOGY CO | $160,756,000 | -14.6% | 4,993,958 | -10.9% | 3.43% | +0.3% |
| ABC | Sell | AMERISOURCEBERGEN CORP | $137,181,000 | -39.1% | 1,032,288 | -45.3% | 2.92% | -28.5% |
| HCA | Sell | HCA HEALTHCARE INC | $123,137,000 | -3.4% | 479,280 | -8.7% | 2.62% | +13.5% |
| DD | Sell | DUPONT DE NEMOURS INC | $121,867,000 | +17.7% | 1,508,632 | -0.9% | 2.60% | +38.4% |
| CNC | Sell | CENTENE CORP DEL | $111,795,000 | -15.5% | 1,356,736 | -36.1% | 2.38% | -0.7% |
| UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $100,696,000 | -17.2% | 776,618 | -11.7% | 2.15% | -2.7% |
| APTV | Sell | APTIV PLC | $88,960,000 | -27.5% | 539,317 | -34.5% | 1.90% | -14.8% |
| WLTW | Sell | WILLIS TOWERS WATSON PLC LTD | $86,208,000 | -55.5% | 362,996 | -56.4% | 1.84% | -47.7% |
| FMC | Sell | FMC CORP | $84,825,000 | +20.0% | 771,911 | -0.0% | 1.81% | +41.0% |
| ESI | Sell | ELEMENT SOLUTIONS INC | $56,903,000 | -4.7% | 2,343,601 | -14.9% | 1.21% | +12.1% |
| BKD | Sell | BROOKDALE SR LIVING INC | $52,692,000 | -37.8% | 10,211,649 | -24.1% | 1.12% | -26.9% |
| FISV | Sell | FISERV INC | $51,813,000 | -22.5% | 499,206 | -18.9% | 1.10% | -8.9% |
| NSC | Sell | NORFOLK SOUTHN CORP | $51,564,000 | -22.4% | 173,203 | -37.7% | 1.10% | -8.8% |
| CHNG | Sell | CHANGE HEALTHCARE INC | $47,695,000 | -0.2% | 2,230,811 | -2.3% | 1.02% | +17.2% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $46,672,000 | -47.9% | 1,098,684 | -46.8% | 1.00% | -38.7% |
| MYGN | Sell | MYRIAD GENETICS INC | $46,361,000 | -35.8% | 1,679,747 | -24.8% | 0.99% | -24.5% |
| HOLX | Sell | HOLOGIC INC | $44,812,000 | -13.3% | 585,321 | -16.4% | 0.96% | +1.9% |
| UNP | Sell | UNION PAC CORP | $42,974,000 | -33.5% | 170,579 | -48.2% | 0.92% | -21.8% |
| NSP | Sell | INSPERITY INC | $40,472,000 | -28.5% | 342,664 | -33.0% | 0.86% | -16.1% |
| GOOGL | Sell | ALPHABET INCcap stk cl a | $35,242,000 | -73.8% | 12,165 | -75.8% | 0.75% | -69.2% |
| HUM | Sell | HUMANA INC | $25,502,000 | -63.6% | 54,978 | -69.5% | 0.54% | -57.2% |
| FLEX | Sell | FLEX LTDord | $18,330,000 | -7.1% | 1,000,000 | -10.4% | 0.39% | +9.2% |
| IS | Sell | IRONSOURCE LTD | $15,230,000 | -66.1% | 1,967,668 | -52.4% | 0.32% | -60.2% |
| ENDP | Sell | ENDO INTL PLC | $8,201,000 | -61.4% | 2,181,239 | -66.7% | 0.18% | -54.5% |
| OHPAU | Sell | ORION ACQUISITION CORPunit 02/19/2026 | $4,777,000 | -3.3% | 485,001 | -3.0% | 0.10% | +13.3% |
| Sell | EVOLV TECHNOLOGIES HLDNGS IN | $3,343,000 | -34.5% | 749,461 | -11.8% | 0.07% | -22.8% | |
| VELOW | Exit | VELOCITY ACQUISITION CORP*w exp 02/24/202 | $0 | – | -244,060 | -100.0% | -0.00% | – |
| ATIPWS | Exit | ATI PHYSICAL THERAPY INC*w exp 08/10/202 | $0 | – | -300,000 | -100.0% | -0.00% | – |
| ATIP | Exit | ATI PHYSICAL THERAPY INC | $0 | – | -249,145 | -100.0% | -0.02% | – |
| BOWX | Exit | BOWX ACQUISITION CORPcl a | $0 | – | -757,294 | -100.0% | -0.14% | – |
| FST | Exit | FAST ACQUISITION CORP | $0 | – | -878,761 | -100.0% | -0.20% | – |
| OGN | Exit | ORGANON & CO | $0 | – | -753,127 | -100.0% | -0.45% | – |
| Exit | CCC INTELLIGENT SOLUTIONS HL | $0 | – | -2,405,960 | -100.0% | -0.46% | – | |
| V | Exit | VISA INC | $0 | – | -134,630 | -100.0% | -0.54% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -88,011 | -100.0% | -0.60% | – |
| FB | Exit | FACEBOOK INCcl a | $0 | – | -205,401 | -100.0% | -1.26% | – |
| MOH | Exit | MOLINA HEALTHCARE INC | $0 | – | -330,105 | -100.0% | -1.62% | – |
| VIAC | Exit | VIACOMCBS INCcl b | $0 | – | -2,667,822 | -100.0% | -1.91% | – |
| TAK | Exit | TAKEDA PHARMACEUTICAL CO LTDsponsored ads | $0 | – | -8,102,119 | -100.0% | -2.41% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
About Glenview Capital Management
Glenview Capital Management is a well-known investment management firm that was founded in 2001 by Larry Robbins. The company is headquartered in New York City and manages over $10 billion in assets. Glenview Capital Management is known for its long-term investment strategy and its focus on fundamental analysis. The company invests in a wide range of industries, including healthcare, technology, and consumer goods.
Larry Robbins, the CEO and founder of Glenview Capital Management, is a well-respected figure in the finance industry. He has been recognized for his investment expertise and has been featured in numerous publications, including Forbes and The Wall Street Journal. In addition to Robbins, Glenview Capital Management has a team of experienced professionals, including COO Mark Horowitz and Chief Investment Officer Lee Ainslie.
Glenview Capital Management has a strong track record of delivering solid returns to its investors. The company's investment philosophy is centered around identifying undervalued companies with strong fundamentals and holding them for the long-term. This approach has proven successful, as Glenview Capital Management has consistently outperformed the market over the years.
Overall, Glenview Capital Management is a reputable investment management firm with a strong team of professionals and a proven investment strategy. While past performance is not indicative of future results, investors looking for a long-term investment strategy may want to consider Glenview Capital Management as a potential investment option.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TENET HEALTHCARE CORP | 42 | Q3 2023 | 16.7% |
| HCA HOLDINGS INC | 42 | Q3 2023 | 9.1% |
| MCKESSON CORP | 40 | Q3 2023 | 8.2% |
| FLEXTRONICS INTL LTD | 38 | Q2 2023 | 4.5% |
| BROOKDALE SR LIVING INC | 38 | Q3 2023 | 2.1% |
| MERITOR INC | 36 | Q1 2022 | 3.0% |
| FMC CORP | 34 | Q2 2023 | 6.4% |
| UNIVERSAL HLTH SVCS INC | 34 | Q3 2023 | 5.0% |
| HUMANA INC | 31 | Q4 2021 | 12.1% |
| ENDO INTL PLC | 30 | Q1 2022 | 2.8% |
View Glenview Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Butterfly Network, Inc. | February 14, 2023 | 9,746,834 | 5.5% |
| Quantum-Si Inc | February 14, 2023 | 4,249,956 | 3.6% |
| MERITOR, INC. | February 22, 2022 | 3,544,333 | 5.0% |
| ATI Physical Therapy, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Evolv Technologies Holdings, Inc. | February 14, 2022 | 749,461 | 0.5% |
| Velocity Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
| Bausch Health Companies Inc. | December 13, 2021 | 17,078,657 | 4.8% |
| NewHold Investment Corp. | June 04, 2021 | 1,114,862 | 6.5% |
| Longview Acquisition Corp. II | April 02, 2021 | 5,000,000 | 7.2% |
| HighCape Capital Acquisition Corp. | March 15, 2021 | 1,033,739 | 8.7% |
View Glenview Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-01-16 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
View Glenview Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.